Skip to content
  • About
    • Mission/Vision
    • Our Team
    • Board of Directors
    • Elite Members
    • Partnerships
  • Membership
    • Why Join BioUtah?
    • Membership Prospectus
    • Member Login
    • Apply for Membership
    • Member Discounts
    • Non-dilutive Funding
    • Membership Directory
  • Advocacy
  • News/Info
    • Life Sciences News
    • Biosphere Magazine
    • Podcasts
    • Reports/Publications
  • Events
    • BioUtah Events
    • Industry Events
  • Subscribe to Newsletter

About:Press Release

Posts by Press Release :

Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights

Posted on September 24, 2022 by Press Release

Dynatronics reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.
[…]

Read More

nView s1 reaches its 100th surgery

Posted on September 19, 2022 by Press Release

The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at six leading pediatric facilities, including three of the top 10 facilities in the nation. […]

Read More

EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL

Posted on September 15, 2022 by Press Release

Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve. […]

Read More

PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update

Posted on August 15, 2022 by Press Release

PolarityTE provided a business update and reported financial results for the quarterly period ended June 30, 2022. […]

Read More

Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Posted on August 15, 2022 by Press Release

Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform […]

Read More

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia

Posted on August 15, 2022 by Press Release

The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336. […]

Read More

New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models

Posted on August 15, 2022 by Press Release

Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses […]

Read More

Merit Medical Launches SafeGuard Focus Cool™ Compression Device

Posted on August 15, 2022 by Press Release

Modern design advances patient care by combining hemostasis with innovative cooling capability […]

Read More

Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelXTM with Primary Care Physicians

Posted on August 8, 2022 by Press Release

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b. […]

Read More

Soft Cell Labs announces new Urinary Tract Infection Test

Posted on August 15, 2022 by Press Release

Soft Cell Labs announces new Urinary Tract Infection Test […]

Read More

ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories

Posted on August 6, 2022 by Press Release

ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers […]

Read More

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

Posted on August 4, 2022 by Press Release

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS® […]

Read More

  • «
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 57
  • »
  1. Home
  2. Articles Posted by Press Release
  3. (Page 37)

Copyright © 2026 BioUtah. Powered by Visualmodo.